Publication & Citation Trends
Publications
0 total
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial
Cited by 0
Semantic Scholar
OS09.7.A GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB
Cited by 9
Semantic Scholar
LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
Cited by 1
Semantic Scholar
CTNI-85. GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB OA
Cited by 7
Semantic Scholar
P11.29.B UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA OA
Cited by 3
Semantic Scholar
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE OA
Cited by 159
Semantic Scholar
Genetics and malignant progression of human brain tumours.
Cited by 77
Semantic Scholar
Research Topics
Glioma Diagnosis and Treatment
(94)
Cancer-related Molecular Pathways
(72)
Cancer Genomics and Diagnostics
(62)
Cancer, Hypoxia, and Metabolism
(58)
PI3K/AKT/mTOR signaling in cancer
(47)
Affiliations
University of North Carolina at Chapel Hill
University of Southern California
Tufts University
Fleet Science Center
Boston Children's Hospital